Dermoscopy and reflectance confocal microscopy for basal cell carcinoma diagnosis and diagnosis prediction score: a prospective and multicenter study on 1005 lesions.

basal cell carcinoma dermatoscopy dermoscopy diagnosis imaging techniques non-invasive diagnosis prospective study: diagnostic accuracy reflectance confocal microscopy sensitivity skin cancer specificity

Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
29 Jan 2024
Historique:
received: 05 09 2023
revised: 25 11 2023
accepted: 05 01 2024
medline: 1 2 2024
pubmed: 1 2 2024
entrez: 31 1 2024
Statut: aheadofprint

Résumé

Basal cell carcinoma is usually diagnosed by clinical and dermoscopy examination, but diagnostic accuracy may be suboptimal. Reflectance confocal microscopy (RCM) imaging increases skin cancer diagnostic accuracy. To evaluate additional benefit in diagnostic accuracy of handheld RCM in a prospective controlled clinical setting METHODS: A prospective, multicenter study in 3 skin cancer reference centers in Italy enrolling consecutive lesions with clinical-dermoscopic suspicion of basal cell carcinoma. gov; NCT04789421 RESULTS: A total of 1005 lesions were included, of which 474 histopathologically confirmed versus 531 diagnosed by clinical-dermoscopic-RCM correlation, confirmed with 2 years of follow up. Specifically, 740 were confirmed basal cell carcinomas. Sensitivity and specificity for dermoscopy alone was 93.2% (CI 95% 91.2 - 94.9) and 51.7% (CI 95% 45.5 - 57.9); PPV was 84.4 (CI 95% 81.7 - 86.8) and NPV 73.3 (66.3 - 79.5). Adjunctive reflectance confocal microscopy reported higher rates: 97.8 (CI 95% 96.5 - 98.8) sensitivity and 86.8 (CI 95% 82.1 - 90.6) specificity, with PPV of 95.4 (CI 95% 93.6 - 96.8) and NPV 93.5 (89.7 - 96.2). Study conducted in one single Country CONCLUSION: Adjunctive handheld RCM assessment of lesions clinically suspicious for basal cell carcinoma permits higher diagnostic accuracy with minimal false negative lesions.

Sections du résumé

BACKGROUND BACKGROUND
Basal cell carcinoma is usually diagnosed by clinical and dermoscopy examination, but diagnostic accuracy may be suboptimal. Reflectance confocal microscopy (RCM) imaging increases skin cancer diagnostic accuracy.
OBJECTIVE OBJECTIVE
To evaluate additional benefit in diagnostic accuracy of handheld RCM in a prospective controlled clinical setting METHODS: A prospective, multicenter study in 3 skin cancer reference centers in Italy enrolling consecutive lesions with clinical-dermoscopic suspicion of basal cell carcinoma.
CLINICALTRIALS RESULTS
gov; NCT04789421 RESULTS: A total of 1005 lesions were included, of which 474 histopathologically confirmed versus 531 diagnosed by clinical-dermoscopic-RCM correlation, confirmed with 2 years of follow up. Specifically, 740 were confirmed basal cell carcinomas. Sensitivity and specificity for dermoscopy alone was 93.2% (CI 95% 91.2 - 94.9) and 51.7% (CI 95% 45.5 - 57.9); PPV was 84.4 (CI 95% 81.7 - 86.8) and NPV 73.3 (66.3 - 79.5). Adjunctive reflectance confocal microscopy reported higher rates: 97.8 (CI 95% 96.5 - 98.8) sensitivity and 86.8 (CI 95% 82.1 - 90.6) specificity, with PPV of 95.4 (CI 95% 93.6 - 96.8) and NPV 93.5 (89.7 - 96.2).
LIMITATIONS CONCLUSIONS
Study conducted in one single Country CONCLUSION: Adjunctive handheld RCM assessment of lesions clinically suspicious for basal cell carcinoma permits higher diagnostic accuracy with minimal false negative lesions.

Identifiants

pubmed: 38296197
pii: S0190-9622(24)00135-X
doi: 10.1016/j.jaad.2024.01.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Caterina Longo (C)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy.

Stefania Guida (S)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Dermatology Clinic, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: guida.stefania@hsr.it.

Marica Mirra (M)

Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy.

Riccardo Pampena (R)

Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy.

Silvana Ciardo (S)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Sara Bassoli (S)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Alice Casari (A)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Franco Rongioletti (F)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Dermatology Clinic, IRCCS San Raffaele Hospital, Milan, Italy.

Marco Spadafora (M)

Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Johanna Chester (J)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Shaniko Kaleci (S)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Michela Lai (M)

Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Serena Magi (S)

Dermatology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy; Skin Cancer Unit IRCCS IRST, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), Italy.

Laura Mazzoni (L)

Dermatology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy; Skin Cancer Unit IRCCS IRST, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), Italy.

Francesca Farnetani (F)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Ignazio Stanganelli (I)

Dermatology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy; Skin Cancer Unit IRCCS IRST, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), Italy.

Giovanni Pellacani (G)

Dermatology, Department of Clinical Internal Anesthesiologic Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Classifications MeSH